Kezar Life Sciences CEO John Fowler's 2019 pay jumps 96% to $3.5M
Kezar Life Sciences reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Kezar Life Sciences reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at Kezar Life Sciences received on average a compensation package of $2.3M, a 74% increase compared to previous year.
Average pay of disclosed executives at Kezar Life Sciences
John Fowler, Chief Executive Officer, received $3.5M in total, which increased by 96% compared to 2018. 80% of Fowler's compensation, or $2.8M, was in option awards. Fowler also received $184K in non-equity incentive plan, $525K in salary, as well as $12K in other compensation.
Niti Goel, Chief Medical Officer, received a compensation package of $2.1M, which increased by 77% compared to previous year. 57% of the compensation package, or $1.2M, was in option awards.
Christopher Kirk, Chief Scientific Officer, earned $1.9M in 2019, a 102% increase compared to previous year.
Marc Belsky, Chief Financial Officer, received $1.6M in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.